Literature DB >> 27409973

Glasgow Coma Scale Score in Survivors of Explosion With Possible Traumatic Brain Injury in Need of Neurosurgical Intervention.

Itamar Ashkenazi1, William P Schecter2, Kobi Peleg3, Adi Givon4, Oded Olsha5, Fernando Turegano-Fuentes6, Ricardo Alfici1, Hany Bahouth7, Alexander Becker8, Michael Ben Ely9, Alexander Braslavsky10, Igor Jeroukhimov11, Milad Qarawany12, Boris Kessel13, Yoram Klein14, Guy Lin15, Ofer Merin16, Miklosh Bala17, Youri Mnouskin18, Avraham I Rivkind17, Gad Shaked19, Dror Soffer20, Michael Stein21, Michael Weiss22.   

Abstract

Importance: Head injury following explosions is common. Rapid identification of patients with severe traumatic brain injury (TBI) in need of neurosurgical intervention is complicated in a situation where multiple casualties are admitted following an explosion. Objective: To evaluate whether Glasgow Coma Scale (GCS) score or the Simplified Motor Score at presentation would identify patients with severe TBI in need of neurosurgical intervention. Design, Setting, and Participants: Analysis of clinical data recorded in the Israel National Trauma Registry of 1081 patients treated following terrorist bombings in the civilian setting between 1998 and 2005. Primary analysis of the data was conducted in 2009, and analysis was completed in 2015. Main Outcomes and Measures: Proportion of patients with TBI in need of neurosurgical intervention per GCS score or Simplified Motor Score.
Results: Of 1081 patients (median age, 29 years [range, 0-90 years]; 38.9% women), 198 (18.3%) were diagnosed as having TBI (48 mild and 150 severe). Severe TBI was diagnosed in 48 of 877 patients (5%) with a GCS score of 15 and in 99 of 171 patients (58%) with GCS scores of 3 to 14 (P < .001). In 65 patients with abnormal GCS (38%), no head injury was recorded. Nine of 877 patients (1%) with a GCS score of 15 were in need of a neurosurgical operation, and fewer than 51 of the 171 patients (30%) with GCS scores of 3 to 14 had a neurosurgical operation (P < .001). No difference was found between the proportion of patients in need of neurosurgery with GCS scores of 3 to 8 and those with GCS scores of 9 to 14 (30% vs 27%; P = .83). When the Simplified Motor Score and GCS were compared with respect to their ability to identify patients in need of neurosurgical interventions, no difference was found between the 2 scores. Conclusions and Relevance: Following an explosion in the civilian setting, 65 patients (38%) with GCS scores of 3 to 14 did not experience severe TBI. The proportion of patients with severe TBI and severe TBI in need of a neurosurgical intervention were similar in patients presenting with GCS scores of 3 to 8 and GCS scores of 9 to 14. In this study, GCS and Simplified Motor Score did not help identify patients with severe TBI in need of a neurosurgical intervention.

Entities:  

Mesh:

Year:  2016        PMID: 27409973     DOI: 10.1001/jamasurg.2016.1742

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  4 in total

1.  Clinical Evaluation of a Microwave-Based Device for Detection of Traumatic Intracranial Hemorrhage.

Authors:  Johan Ljungqvist; Stefan Candefjord; Mikael Persson; Lars Jönsson; Thomas Skoglund; Mikael Elam
Journal:  J Neurotrauma       Date:  2017-03-13       Impact factor: 5.269

2.  Delirium after a traumatic brain injury: predictors and symptom patterns.

Authors:  Jutaporn Maneewong; Benchalak Maneeton; Narong Maneeton; Tanat Vaniyapong; Patrinee Traisathit; Natthanidnan Sricharoen; Manit Srisurapanont
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-14       Impact factor: 2.570

3.  Comparison of full outline of unresponsiveness score and Glasgow Coma Scale in Medical Intensive Care Unit.

Authors:  Jamileh Ramazani; Mohammad Hosseini
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun

4.  Use of the Braden Scale to Predict Injury Severity in Mass Burn Casualties.

Authors:  Zhikang Zhu; Bin Xu; Jiaming Shao; Shuangshuang Wang; Ronghua Jin; Tingting Weng; Sizhan Xia; Wei Zhang; Min Yang; Chunmao Han; Xingang Wang
Journal:  Med Sci Monit       Date:  2022-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.